Stock Scorecard
Stock Summary for Lucid Diagnostics Inc (LUCD) - $1.25 as of 2/3/2026 10:07:49 PM EST
Total Score
8 out of 30
Safety Score
20 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for LUCD
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for LUCD
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for LUCD
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for LUCD
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for LUCD (20 out of 100)
| Stock Price Rating (Max of 10) | 2 |
| Historical Stock Price Rating (Max of 10) | 2 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for LUCD
Financial Details for LUCD
Company Overview |
|
|---|---|
| Ticker | LUCD |
| Company Name | Lucid Diagnostics Inc |
| Country | USA |
| Description | Lucid Diagnostics Inc. is a pioneering medical diagnostic technology firm based in New York, focused on revolutionizing early cancer detection through cutting-edge diagnostic tests. Leveraging advanced technologies, Lucid develops innovative solutions that enhance clinical decision-making and aim to substantially improve patient outcomes in oncology. With a strong commitment to addressing critical healthcare gaps, the company is positioned to emerge as a significant force in the medical diagnostics landscape, driving transformative breakthroughs in cancer treatment and elevating the standard of care for patients. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 3/23/2026 |
Stock Price History |
|
| Last Day Price | 1.25 |
| Price 4 Years Ago | 1.36 |
| Last Day Price Updated | 2/3/2026 10:07:49 PM EST |
| Last Day Volume | 758,500 |
| Average Daily Volume | 1,913,368 |
| 52-Week High | 1.80 |
| 52-Week Low | 0.91 |
| Last Price to 52 Week Low | 37.36% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 54.83 |
| Sector PE | 188.49 |
| 5-Year Average PE | -1.79 |
| Free Cash Flow Ratio | 3.47 |
| Industry Free Cash Flow Ratio | 19.78 |
| Sector Free Cash Flow Ratio | 30.14 |
| Current Ratio Most Recent Quarter | 1.90 |
| Total Cash Per Share | 0.36 |
| Book Value Per Share Most Recent Quarter | -0.23 |
| Price to Book Ratio | 2.16 |
| Industry Price to Book Ratio | 3.56 |
| Sector Price to Book Ratio | 57.14 |
| Price to Sales Ratio Twelve Trailing Months | 38.15 |
| Industry Price to Sales Ratio Twelve Trailing Months | 6.56 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.56 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 131,099,000 |
| Market Capitalization | 163,873,750 |
| Institutional Ownership | 29.00% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 13.55% |
| Reported EPS 12 Trailing Months | -0.77 |
| Reported EPS Past Year | -0.36 |
| Reported EPS Prior Year | -1.02 |
| Net Income Twelve Trailing Months | -10,439,888,000 |
| Net Income Past Year | -45,529,000 |
| Net Income Prior Year | -52,666,000 |
| Quarterly Revenue Growth YOY | 3.30% |
| 5-Year Revenue Growth | 120.36% |
| Operating Margin Twelve Trailing Months | -971.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 47,332,000 |
| Total Cash Past Year | 22,358,000 |
| Total Cash Prior Year | 18,896,000 |
| Net Cash Position Most Recent Quarter | 37,132,000 |
| Net Cash Position Past Year | 8,408,000 |
| Long Term Debt Past Year | 13,950,000 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 10,200,000 |
| Equity to Debt Ratio Past Year | 0.28 |
| Equity to Debt Ratio Most Recent Quarter | 0.72 |
| Total Stockholder Equity Past Year | 5,391,000 |
| Total Stockholder Equity Prior Year | -2,311,000 |
| Total Stockholder Equity Most Recent Quarter | 25,835,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -44,183,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.34 |
| Free Cash Flow Past Year | -44,786,000 |
| Free Cash Flow Prior Year | -33,038,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 1.22 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 2/3/2026 10:07:50 PM EST |